Who are Palifermin before and after's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/palifermin-before-and-after.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Palifermin before and after — Competitive Intelligence Brief

Palifermin before and after (Palifermin before and after) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Keratinocyte growth factor (KGF) receptor agonist. Area: Oncology.

phase 3 Keratinocyte growth factor (KGF) receptor agonist FGFR2 (Fibroblast Growth Factor Receptor 2) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Palifermin before and after (Palifermin before and after) — Swedish Orphan Biovitrum. Palifermin is a keratinocyte growth factor (KGF) receptor agonist that stimulates epithelial cell proliferation and differentiation to protect and repair oral mucosa.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Palifermin before and after TARGET	Palifermin before and after	Swedish Orphan Biovitrum	phase 3	Keratinocyte growth factor (KGF) receptor agonist	FGFR2 (Fibroblast Growth Factor Receptor 2)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Keratinocyte growth factor (KGF) receptor agonist class)

Swedish Orphan Biovitrum · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Palifermin before and after — Competitive Intelligence Brief. https://druglandscape.com/ci/palifermin-before-and-after. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab